Anti-inflammatory properties of drugs used to control COVID-19 and their effects on the renin-angiotensin system and angiotensin-converting enzyme-2

H Gilzad-Kohan, F Jamali - Journal of Pharmacy & …, 2020 - journals.library.ualberta.ca
COVID-19 infection is associated with systemic inflammation, and sometimes
hyperinflammatory responses with cytokine storm. This plays a major role in COVID-19 …

COVID-19 pandemic and therapy with ibuprofen or renin-angiotensin system blockers: no need for interruptions or changes in ongoing chronic treatments

O Zolk, S Hafner, CQ Schmidt… - Naunyn-schmiedeberg's …, 2020 - Springer
Scientists hypothesized that drugs such as ibuprofen or renin-angiotensin system (RAS)
blockers could exacerbate the novel coronavirus disease COVID-19 by upregulating the …

Bioactive compounds as potential angiotensin-converting enzyme II inhibitors against COVID-19: a scoping review

PH de Matos, TP da Silva, AB Mansano… - Inflammation …, 2022 - Springer
Objective and design The current study aimed to summarize the evidence of compounds
contained in plant species with the ability to block the angiotensin-converting enzyme 2 …

[HTML][HTML] Renin-angiotensin-aldosterone system (RAAS) inhibitors and coronavirus disease 2019 (COVID-19)

AAD Albashir - Southern Medical Journal, 2021 - ncbi.nlm.nih.gov
Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) is the virus responsible for
the coronavirus disease 2019 (COVID-19) pandemic. The angiotensin-converting enzyme 2 …

Drugs modulating renin-angiotensin system in COVID-19 treatment

JL Labandeira-Garcia, CM Labandeira, R Valenzuela… - Biomedicines, 2022 - mdpi.com
A massive worldwide vaccination campaign constitutes the main tool against the COVID-19
pandemic. However, drug treatments are also necessary. Antivirals are the most frequently …

Treatment for COVID-19: An overview

C Stasi, S Fallani, F Voller, C Silvestri - European journal of pharmacology, 2020 - Elsevier
Abstract Coronavirus disease 2019 (COVID-19) is an infectious disease caused by
coronavirus-2 (SARS-CoV-2) that causes a severe acute respiratory syndrome, a …

Angiotensin-converting enzyme 2 roles in the pathogenesis of COVID-19

A Kenarkoohi, M Maleki, T Safari… - Current hypertension …, 2021 - ingentaconnect.com
The new pandemic Coronavirus Disease 2019 (COVID-19) causes a wide range of clinical
consequences, from asymptomatic infection to acute respiratory failure, and it is very …

The impact of angiotensin-converting enzyme-2/angiotensin 1-7 Axis in establishing severe COVID-19 consequences

MA Maranduca, DM Tanase, CT Cozma, N Dima… - Pharmaceutics, 2022 - mdpi.com
The COVID-19 pandemic has put a tremendous stress on the medical community over the
last two years. Managing the infection proved a lot more difficult after several research …

Might renin–angiotensin system blockers play a role in the COVID-19 pandemic?

A Battistoni, M Volpe - European Heart Journal-Cardiovascular …, 2020 - academic.oup.com
Since December 2019, a new coronavirus, named SARS-CoV-2, has spread globally,
affecting> 200 000 people worldwide with the so-called COVID-19 disease. The scientific …

Experimental data using candesartan and captopril indicate no double-edged sword effect in COVID-19

MA Pedrosa, R Valenzuela, P Garrido-Gil… - Clinical …, 2021 - portlandpress.com
The key link between renin–angiotensin system (RAS) and COVID-19 is ACE2 (angiotensin-
converting enzyme 2), which acts as a double-edged sword, because ACE2 increases the …